DBV Technologies | Gewinn Vor Steuern



Pre Tax Profit Veränderung Datum
Acadia Pharmaceuticals USD 27.78M 133.31M 2025-03
Alnylam Pharmaceuticals USD -35358000 6.24M 2025-06
Amarin USD -13630000 197K 2025-03
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
DBV Technologies EUR -23008000 7.43M 2024-12
Halozyme Therapeutics USD 557.13M 359.8M 2024-12
Incyte USD 558.01M 323.82M 2025-06
Insmed USD -255671000 21.39M 2025-03
Ionis Pharmaceuticals USD 124M 271M 2025-06
Neurocrine Biosciences USD 159.5M 144.8M 2025-06
PTC Therapeutics USD -94699000 3.29M 2024-12
Sarepta Therapeutics USD -383518000 555.26M 2025-03
Ultragenyx Pharmaceutical USD -133404000 191K 2024-12
United Therapeutics USD 408.4M 15.1M 2025-06


DBV Technologies Gewinn Vor Steuern - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.